![Braz J Cardiovasc Surg - <i>Allium sativum</i> Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia Braz J Cardiovasc Surg - <i>Allium sativum</i> Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia](https://cdn.publisher.gn1.link/bjcvs.org/imagensRBCCV/v31n4a05-fig03.jpg)
Braz J Cardiovasc Surg - <i>Allium sativum</i> Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia
![Cilostazol as a noninferiority pharmacologic option to paclitaxel in early intimal hyperplasia inhibition after venous balloon angioplasty in a rabbit model: a preliminary study - JVS-Vascular Science Cilostazol as a noninferiority pharmacologic option to paclitaxel in early intimal hyperplasia inhibition after venous balloon angioplasty in a rabbit model: a preliminary study - JVS-Vascular Science](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/5bc7c219-4cec-4789-8468-6978fdeb9ffd/gr3.jpg)
Cilostazol as a noninferiority pharmacologic option to paclitaxel in early intimal hyperplasia inhibition after venous balloon angioplasty in a rabbit model: a preliminary study - JVS-Vascular Science
![Atorvastatin Reduces Accumulation of Vascular Smooth Muscle Cells to Inhibit Intimal Hyperplasia via p38 MAPK Pathway Inhibition in a Rat Model of Vein Graft. - Abstract - Europe PMC Atorvastatin Reduces Accumulation of Vascular Smooth Muscle Cells to Inhibit Intimal Hyperplasia via p38 MAPK Pathway Inhibition in a Rat Model of Vein Graft. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8386959/bin/0066-782X-abc-115-04-0630-gf02.jpg)
Atorvastatin Reduces Accumulation of Vascular Smooth Muscle Cells to Inhibit Intimal Hyperplasia via p38 MAPK Pathway Inhibition in a Rat Model of Vein Graft. - Abstract - Europe PMC
![Modelo experimental biológico y molecular de fuerza tensional para el estudio fisiopatológico de la hiperplasia intimal venosa Modelo experimental biológico y molecular de fuerza tensional para el estudio fisiopatológico de la hiperplasia intimal venosa](https://www.scielo.org.mx/img/revistas/rmang/v48n1//0377-4740-rma-48-1-17-gf1.jpg)
Modelo experimental biológico y molecular de fuerza tensional para el estudio fisiopatológico de la hiperplasia intimal venosa
![Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target - ScienceDirect Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359644616301921-gr7.jpg)
Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target - ScienceDirect
![Area of intimal hyperplasia at the midportion of the anastomoses in... | Download Scientific Diagram Area of intimal hyperplasia at the midportion of the anastomoses in... | Download Scientific Diagram](https://www.researchgate.net/profile/Jan-Brunkwall-2/publication/6319657/figure/fig3/AS:280467401134081@1443880047138/Area-of-intimal-hyperplasia-at-the-midportion-of-the-anastomoses-in-control-and.png)
Area of intimal hyperplasia at the midportion of the anastomoses in... | Download Scientific Diagram
Diferença da hiperplasia miointimal em coelhos submetidos a angioplastia e tratados com Moringa oleifera.
![Relationship Between Plasma C-Reactive Protein Level and Neointimal Hyperplasia Volume in Patients With Zotarolimus-Eluting Stents. Volumetric Analysis by Three-Dimensional Intracoronary Ultrasound | Revista Española de Cardiología Relationship Between Plasma C-Reactive Protein Level and Neointimal Hyperplasia Volume in Patients With Zotarolimus-Eluting Stents. Volumetric Analysis by Three-Dimensional Intracoronary Ultrasound | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/thumbnail/13114109:255v60n09-13114109fig03.jpg)
Relationship Between Plasma C-Reactive Protein Level and Neointimal Hyperplasia Volume in Patients With Zotarolimus-Eluting Stents. Volumetric Analysis by Three-Dimensional Intracoronary Ultrasound | Revista Española de Cardiología
![Cilostazol as a noninferiority pharmacologic option to paclitaxel in early intimal hyperplasia inhibition after venous balloon angioplasty in a rabbit model: a preliminary study - JVS-Vascular Science Cilostazol as a noninferiority pharmacologic option to paclitaxel in early intimal hyperplasia inhibition after venous balloon angioplasty in a rabbit model: a preliminary study - JVS-Vascular Science](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fb27bbf5-7c3e-417c-879c-b5295fde57af/gr1.jpg)
Cilostazol as a noninferiority pharmacologic option to paclitaxel in early intimal hyperplasia inhibition after venous balloon angioplasty in a rabbit model: a preliminary study - JVS-Vascular Science
![Intimal Hyperplasia and Arteriovenous Fistula Failure: Looking Beyond Size Differences | American Society of Nephrology Intimal Hyperplasia and Arteriovenous Fistula Failure: Looking Beyond Size Differences | American Society of Nephrology](https://kidney360.asnjournals.org/content/2/8/1360/F1.large.jpg)
Intimal Hyperplasia and Arteriovenous Fistula Failure: Looking Beyond Size Differences | American Society of Nephrology
![Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target - ScienceDirect Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1359644616301921-gr5.jpg)
Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target - ScienceDirect
![Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes - American Journal of Kidney Diseases Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes - American Journal of Kidney Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6989277c-3e6b-40c8-b7dc-98a6e651b368/gr5.jpg)
Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes - American Journal of Kidney Diseases
![Figure 4 from Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target. | Semantic Scholar Figure 4 from Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cacdfe4dacbd30c325d4e36947a84283a893386c/6-Figure4-1.png)
Figure 4 from Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target. | Semantic Scholar
![Comparison of Neointimal Coverage by Optical Coherence Tomography of a Sirolimus-Eluting Stent Versus a Bare-Metal Stent Three Months After Implantation - American Journal of Cardiology Comparison of Neointimal Coverage by Optical Coherence Tomography of a Sirolimus-Eluting Stent Versus a Bare-Metal Stent Three Months After Implantation - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e856d545-8f2f-40c5-bc8b-66dd0292d164/gr1.jpg)
Comparison of Neointimal Coverage by Optical Coherence Tomography of a Sirolimus-Eluting Stent Versus a Bare-Metal Stent Three Months After Implantation - American Journal of Cardiology
![La arteriolopatía calcificante urémica (calcifilaxis) en el contexto del síndrome metabólico y la diabetes mellitus. Perspectiva actual | Nefrología La arteriolopatía calcificante urémica (calcifilaxis) en el contexto del síndrome metabólico y la diabetes mellitus. Perspectiva actual | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/X0211699508033475:526127_figura1.jpg?idApp=UINPBA000064)